Ayako Ura, Takuo Hayashi, Kazumasa Komura, Masaki Hosoya, Kazuya Takamochi, Eiichi Sato, . . . the Tokyo Metropolitan Innovative Oncology Research Group. (2024). Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma. Wiley.
Chicago Style (17th ed.) CitationAyako Ura, et al. Copy Number Loss of KDM5D May Be a Predictive Biomarker for ATR Inhibitor Treatment in Male Patients with Pulmonary Squamous Cell Carcinoma. Wiley, 2024.
MLA (9th ed.) CitationAyako Ura, et al. Copy Number Loss of KDM5D May Be a Predictive Biomarker for ATR Inhibitor Treatment in Male Patients with Pulmonary Squamous Cell Carcinoma. Wiley, 2024.
Warning: These citations may not always be 100% accurate.